Stany Zjednoczone - angielski - NLM (National Library of Medicine)

bryant ranch prepack - sildenafil citrate (unii: bw9b0ze037) (sildenafil - unii:3m7ob98y7h) - sildenafil 20 mg - sildenafil tablets are indicated for the treatment of pulmonary arterial hypertension (who group i) in adults to improve exercise ability and delay clinical worsening. the delay in clinical worsening was demonstrated when sildenafil tablets were added to background epoprostenol therapy [see clinical studies (14) ]. studies establishing effectiveness were short-term (12 to 16 weeks), and included predominately patients with new york heart association (nyha) functional class ii-iii symptoms and idiopathic etiology (71%) or associated with connective tissue disease (ctd) (25%). limitation of use : adding sildenafil to bosentan therapy does not result in any beneficial effect on exercise capacity [see clinical studies (14)]. sildenafil tablets are contraindicated in patients with: - concomitant use of organic nitrates in any form, either regularly or intermittently, because of the greater risk of hypotension [see warnings and precautions (5.2)] . - concomitant use of riociguat, a guanylate cyclase stimulator. p

Australia - angielski - Department of Health (Therapeutic Goods Administration)

accord healthcare pty ltd - sildenafil citrate, quantity: 28.1 mg (equivalent: sildenafil, qty 20 mg) - tablet, film coated - excipient ingredients: magnesium stearate; microcrystalline cellulose; hypromellose; croscarmellose sodium; calcium hydrogen phosphate; titanium dioxide; lactose monohydrate; triacetin - used to treat patients with pulmonary arterial hypertension classified as who functional classes ii and iii, to improve exercise capacity. efficacy has been shown in primary pulmonary hypertension and pulmonary hypertension associated with connective tissue disease. the efficacy of sildenafil citrate 20 mg has not been evaluated in patients currently on bosentan therapy.

Australia - angielski - Department of Health (Therapeutic Goods Administration)

accord healthcare pty ltd - sildenafil citrate, quantity: 28.1 mg (equivalent: sildenafil, qty 20 mg) - tablet, film coated - excipient ingredients: croscarmellose sodium; magnesium stearate; hypromellose; calcium hydrogen phosphate; microcrystalline cellulose; titanium dioxide; lactose monohydrate; triacetin - used to treat patients with pulmonary arterial hypertension classified as who functional classes ii and iii, to improve exercise capacity. efficacy has been shown in primary pulmonary hypertension and pulmonary hypertension associated with connective tissue disease. the efficacy of sildenafil citrate 20 mg has not been evaluated in patients currently on bosentan therapy.

Irlandia - angielski - HPRA (Health Products Regulatory Authority)

ltt pharma limited - sildenafil citrate - film coated tablet - 50 milligram

Irlandia - angielski - HPRA (Health Products Regulatory Authority)

ltt pharma limited - sildenafil citrate - film coated tablet - 100 milligram

Irlandia - angielski - HPRA (Health Products Regulatory Authority)

sanofi-aventis ireland limited t/a sanofi - sildenafil base (as citrate) - film coated tablet - 100 milligram

Irlandia - angielski - HPRA (Health Products Regulatory Authority)

sanofi-aventis ireland limited t/a sanofi - sildenafil base (as citrate) - film coated tablet - 50 milligram

Irlandia - angielski - HPRA (Health Products Regulatory Authority)

sanofi-aventis ireland limited t/a sanofi - sildenafil base (as citrate) - film coated tablet - 25 milligram

Malta - angielski - Medicines Authority

torrent pharma gmbh südwestpark 50, 90459 nürnberg, germany - sildenafil - film-coated tablet - sildenafil 25 mg - urologicals

Malta - angielski - Medicines Authority

torrent pharma gmbh südwestpark 50, 90459 nürnberg, germany - sildenafil - film-coated tablet - sildenafil 50 mg - urologicals